Search for: "Watson v. Bear" Results 81 - 100 of 117
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
1 Apr 2021, 9:03 pm by Alana Sheppard
” Walters highlighted that in Gundy v. [read post]
15 Jun 2004, 11:47 am
Probably in no other way and no other time could she so effectively have brought the attention of millions to bear upon the cause. [read post]
5 Sep 2016, 4:52 pm by INFORRM
More recently, we have received the Opinion of the Advocate General (AG) of the CJEU (in Tele2 Sverige AB v Post- och telestyrelsen and Secretary of State for the Home Department v Tom Watson and Others, Joined Cases C-203/15 and C-698/15, 19 July 2016). [read post]
23 Apr 2018, 1:20 am by Kevin LaCroix
”[12] Shareholders bear the brunt of these abuses; “[i]nvestors always are the ultimate losers when extortionate ‘settlements’ are extracted from issuers. [read post]
26 Feb 2012, 11:48 pm by INFORRM
Firstly, the IPCC and the Metropolitan Police v The Guardian (clause 1). [read post]
21 Feb 2011, 4:07 pm by INFORRM
(Professor Brown notes the English Court of Appeal admitted this in Loutchansky v Times Newspapers Ltd (Nos 2 – 5) [2002] 2 WLR 640 at 653.) [read post]
30 Jun 2010, 6:42 am by Matthew Scarola
Watson contends that current hearings bear “little resemblance” to hearings that took place before the 1980s, and that the Court is now “consummately political. [read post]
2 Feb 2007, 6:52 am
An Epitome of Great Legal Classics 1 v. (1915) Hughes, William Taylor   Office of Constable: Comprising the Laws Relating to High, Petty, and Special Constables, Headboroughs, Tithingmen, Borsholders, and  Watchmen, with an Account of Their Institution and Appointment 1 v. (1840) Willcock, John William   On Conveyancers' Evidence 1 v. (1839) Coventry, Thomas   On the Admissibility of Confessions and… [read post]
8 Feb 2008, 7:00 pm
– Facebook’s contractual rights to users’ photos problematic: (Spicy IP)PharmaEuropean Commission probes pharmaceutical sector: (Philip Brooks),WHO Board sets course on IP, avian flu, tighter publication policy: (Intellectual Property Watch),India: The Competition Act, patents and over hyped drugs: (Part I - Spicy IP), (Part II – Spicy IP), (Part III – Spicy IP),Ignoring not the solution –… [read post]
13 Jun 2008, 3:40 am
You can separately subscribe to the IP Thinktank Global week in Review at the Subscribe page: [duncanbucknell.com] Highlights this week included: ECJ rules trade mark holders cannot stop honest comparative advertising: O2 Holdings Limited and O2 (UK) Limited v Hutchinson 3G UK Limited: (Out-Law), (Catch Us If You Can!!!) [read post]
30 Oct 2018, 4:50 am by Graham Smith
The Bulk Powers Review reveals the extent to which more sophisticated analytical techniques such as anomaly detection and pattern analysis are brought to bear on intercepted material, particul [read post]
26 Apr 2010, 1:30 pm by Tom Goldstein
  But even if he had concluded that the statute was constitutional, that view of the case would have conformed to the widespread view that, under existing Supreme Court precedent, the Second Amendment did not confer a right to bear arms unconnected to service in a militia. [read post]
2 Apr 2010, 5:09 am by charonqc
  After the furore about Tom Watson MP and others blocking government libel reform plans the other day it was ironic that the Court of Appeal handed down some serious common sense and justice the next day  to get a grip on the runaway horse of libel law. [read post]
6 Jun 2023, 1:57 pm by Elin Hofverberg
Vasaloppet, a 90 km long Swedish ski race, bears the name of Gustav Vasa and is inspired by the route Vasa took through Dalarna to escape Christian the II following Stockholm bloodbath. [read post]
7 Mar 2008, 2:00 am
: (IPBiz), US: Proposals for the approval of generic biologics under consideration: (Pharmacapsules@Gowlings), US: A paradigm shift in obviousness for pharma, biotech: (IP Law360), US: USPTO’s Bruce Kisliuk addresses ACI Pharma/biotech patent claim drafting and prosecution conference: (Patent Docs), US: New bill to provide biotech companies Sarbanes-Oxley relief: (California Biotech Law Blog), US: Biotech and pharma companies spent millions on lobbying in 2007: (Patent… [read post]